Bisphosphonates and mortality in women with CKD and the presence or absence of cardiovascular disease

Clinical Journal of the American Society of Nephrology

Volumn 9, Issue 5, 2014, Pages 874-880

  Perkins, Robert M ^a,b   Lester Kirchner, H ^a   Matsushita, Kunihiro ^c   Bucaloiu, Ion D ^b   Norfolk, Evan ^b   Hartle, James E ^b  

^a GEISINGER MEDICAL CENTER   (United States)

^b Nephrology Department   (United States)

^c JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BISPHOSPHONIC ACID DERIVATIVE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN; BONE DENSITY CONSERVATION AGENT;

ADULT; AGED; ARTICLE; CARDIOVASCULAR DISEASE; CHRONIC KIDNEY DISEASE; DISEASE ASSOCIATION; DUAL ENERGY X RAY ABSORPTIOMETRY; FEMALE; FOLLOW UP; HUMAN; MAJOR CLINICAL STUDY; MORTALITY; OBSERVATIONAL STUDY; PREVALENCE; SENSITIVITY ANALYSIS; SURVIVAL RATE; SURVIVAL TIME; TREATMENT OUTCOME; CEREBROVASCULAR ACCIDENT; COMORBIDITY; HEART FAILURE; HEART INFARCTION; PROPORTIONAL HAZARDS MODEL; RENAL INSUFFICIENCY, CHRONIC; RETROSPECTIVE STUDY; RISK FACTOR;

AGED; BONE DENSITY CONSERVATION AGENTS; CARDIOVASCULAR DISEASES; COMORBIDITY; DIPHOSPHONATES; FEMALE; HEART FAILURE; HUMANS; MYOCARDIAL INFARCTION; PROPORTIONAL HAZARDS MODELS; RENAL INSUFFICIENCY, CHRONIC; RETROSPECTIVE STUDIES; RISK FACTORS; STROKE;

EID: 84922482258     PISSN: 15559041     EISSN: 1555905X     Source Type: Journal    
DOI: 10.2215/CJN.07790713     Document Type: Article

References (25)

1. Blacher J, Guerin AP, Pannier B, Marchais SJ, London GM: Arterial calcifications, arterial stiffness, and cardiovascular risk in end-stage renal disease. Hypertension 38: 938–942, 2001
2. London GM: Cardiovascular calcifications in uremic patients: Clinical impact on cardiovascular function. J Am Soc Nephrol 14 [Suppl 4]: S305–S309, 2003
3. Ott SM: Bisphosphonate safety and efficacy in chronic kidney disease. Kidney Int 82: 833–835, 2012
4. Toussaint ND, Lau KK, Strauss BJ, Polkinghorne KR, Kerr PG: Effect of alendronate on vascular calcification in CKD stages 3 and 4: A pilot randomized controlled trial. AmJ Kidney Dis 56: 57–68, 2010
5. Ariyoshi T, Eishi K, Sakamoto I, Matsukuma S, Odate T: Effect of etidronic acid on arterial calcification in dialysis patients. Clin Drug Investig 26: 215–222, 2006
6. Cummings SR, Schwartz AV, Black DM: Alendronate and atrial fibrillation. N Engl J Med 356: 1895–1896, 2007
7. Abrahamsen B, Eiken P, Brixen K: Atrial fibrillation in fracture patients treated with oral bisphosphonates. J Intern Med 265: 581–592, 2009
8. Black DM, Delmas PD, Eastell R, Reid IR, Boonen S, Cauley JA, Cosman F, Lakatos P, Leung PC, Man Z, Mautalen C, Mesenbrink P, Hu H, Caminis J, Tong K, Rosario-Jansen T, Krasnow J, Hue TF, Sellmeyer D, Eriksen EF, Cummings SR; HORIZON Pivotal Fracture Trial: Once-yearly zoledronic acid for treatmentofpostmenopausal osteoporosis. N Engl J Med 356: 1809–1822, 2007
9. Armstrong K: Methods in comparative effectiveness research. J Clin Oncol 30: 4208–4214, 2012
10. Hartle JE, Tang X, Kirchner HL, Bucaloiu ID, Sartorius JA, Pogrebnaya ZV, Akers GA, Carnero GE, Perkins RM: Bis-phosphonate therapy, death, and cardiovascular events among female patients with CKD: A retrospective cohort study. Am J Kidney Dis 59: 636–644, 2012
11. Foreman AJ, Lai GP, Miller DP: Surviving left truncation using PROC PHREG. Presented at the Western Users of SAS Software Meeting, University City, CA, November 5, 2008
12. Levey AS, Stevens LA, Schmid CH, Zhang YL, Castro AF 3rd, Feldman HI, Kusek JW, Eggers P, Van Lente F, Greene T, Coresh J; CKD-EPI (Chronic Kidney Disease Epidemiology Collaboration): A new equation to estimate glomerular filtration rate. Ann Intern Med 150: 604–612, 2009
13. Myers GL, Miller WG, Coresh J, Fleming J, Greenberg N, Greene T, Hostetter T, Levey AS, Panteghini M, Welch M, Eckfeldt JH; National Kidney Disease Education Program Laboratory Working Group: Recommendations for improving serum creatinine measurement: A report from the laboratory working group of the National Kidney Disease Education Program. Clin Chem 52: 5–18, 2006
14. Lafrance JP, Miller DR: Acute kidney injury associates with increased long-term mortality. J Am Soc Nephrol 21: 345–352, 2010
15. National Technical Information Service: Available at: http://www.ntis.gov/. Accessed March 5, 2013
16. Rubin DB: Multiple imputation. In: Multiple Imputation for Nonresponse in Surveys, New York, John Wiley & Sons, 1987, pp 15–19
17. Cohen J, Cohen P: Missing data. In: Applied Multiple Regression; Correlation Analysis for the Behavioral Sciences, Hillsdale, NJ, Erlbaum, 1983, pp 303–320
18. McCaffrey DF, Ridgeway G, Morral AR: Propensity score estimation with boosted regression for evaluating causal effects in observational studies. Psychol Methods 9: 403–425, 2004
19. Cole SR, Hernán MA: Adjusted survival curves with inverse probability weights. Comput Methods Programs Biomed 75: 45–49, 2004
20. FDA: Update of Safety Review Follow-up to the October 1, 2007 Early Communication about the Ongoing Safety Review of Bis-phosphonates, 2008. Available at: http://www.fda.gov/Drugs/DrugSafety/Post-marketDrugSafetyInformationforPatientsandProviders/DrugSa-fetyInformationforHeathcareProfessionals/ucm136201.htm. Accessed March 1, 2013
21. London GM, Marty C, Marchais SJ, Guerin AP, Metivier F, de Vernejoul MC: Arterial calcifications and bone histo-morphometry in end-stage renal disease. J Am Soc Nephrol 15: 1943–1951, 2004
22. Elmariah S, Delaney JA, O’Brien KD, Budoff MJ, Vogel-Claussen J, Fuster V, Kronmal RA, Halperin JL: Bisphsophonate use and prevalence of valvular and vascular calcification in women MESA (the Multi-Ethnic Study of Atherosclerosis). J Am Coll Cardiol 56: 1752–1759, 2010
23. Santos LL, Cavalcanti TB, Bandeira FA: Vascular effects of bis-phosphonates-a systematic review. Clin Med Insights Endocrinol Diabetes 5: 47–54, 2012
24. Ylitalo R, Mo¨nkko¨nen J, Urtti A, Ylitalo P: Accumulation of bis-phosphonates in the aorta and some other tissues of healthy and atherosclerotic rabbits. J Lab Clin Med 127: 200–206, 1996
25. Abedin M, Tintut Y, Demer LL: Vascular calcification: Mechanisms and clinical ramifications. Arterioscler Thromb Vasc Biol 24: 1161–1170, 2004